Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06212765Phase 3Not yet recruiting
A Phase 3 trial of citrulline in Malnutrition, Sarcopenia, sponsored by CHU Grenoble Alpes. Planned start Jan 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06212765.